Teresa Magnes

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer

Richard Greil, Sigrun Greil‐Ressler, Charlotte Schönlieb et al. · Cancer Chemotherapy and Pharmacology · 2018 · 132 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A modified scoring of the <scp>NCCN</scp>‐<scp>IPI</scp> is more accurate in the elderly and is improved by albumin and β₂‐microglobulin

Thomas Melchardt, Katharina Troppan, Clemens Hufnagl et al. · British Journal of Haematology · 2014 · 89 citations

Medicine, Geriatric Medicine, Cancer Immunology +15

Clonal evolution and heterogeneity in metastatic head and neck cancer—An analysis of the Austrian Study Group of Medical Tumour Therapy study group

Thomas Melchardt, Teresa Magnes, Clemens Hufnagl et al. · European Journal of Cancer · 2018 · 33 citations

Medicine, Cancer Biology, Oncology +17

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals

Gordon T. Bolger, Albert Licollari, Amin Tan et al. · Cancer Chemotherapy and Pharmacology · 2018 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM

Florian Huemer, Thomas Melchardt, Bettina Jansko et al. · European Journal Of Haematology · 2019 · 27 citations · Full text

Medicine, Hematology, Oncology +17